Effects of kallidinogenase on retinal edema and size of non-perfused areas in mice with retinal vein occlusion
Kallidinogenase has been used to treat retinal vein occlusion (RVO) in patients, although there are no evidences on the effects of kallidinogenase on the retinal edema and the non-perfused areas in eyes with a RVO. We have established a murine RVO model with retinal edema and non-perfused areas. The...
Main Authors: | Anri Nishinaka, Shinichiro Fuma, Yuki Inoue, Masamitsu Shimazawa, Hideaki Hara |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861317300774 |
Similar Items
-
Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model
by: Yoshifumi Hida, et al.
Published: (2018-06-01) -
Oral kallidinogenase improved visual acuity and maintained chorioretinal blood flow levels after treatment for diabetic macular edema
by: Tsuiki E, et al.
Published: (2018-09-01) -
Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases
by: Zhenyu Wei, et al.
Published: (2018-06-01) -
Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
by: Yun Qian, et al.
Published: (2019-12-01) -
Mechanism of edaravone combined with urinary kallidinogenase for acute cerebral infarction patients
by: Chun-Yan Du, et al.
Published: (2017-03-01)